JPRN-UMIN000007376已完成未知
Efficacy and safety of novel NK-1 antagonist, Fosaprepitant for the prevention of CINV - Efficacy and safety of Fosaprepitant for the prevention of CINV
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients having past history of hypersensitivity to fosaprepitant 2)Used Pimozide
研究者
相似试验
暂停
不适用
Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to conventional synthetic disease-modifying antirheumatic drugs: Comparative study with Filgotinib and interleukin 6 inhibitor examined by clinical index as well as musculoskeletal ultrasound assessment(TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trialRheumatoid arthritisJPRN-jRCTs071200107Kawakami Atsushi400
进行中（未招募）
1 期
Clinical trial to evaluate the efficacy, safety and pharmacokinetics profile of nebulized Aztreonam Lysine (AZLI) for prevention of Gram negative pneumonia in heavily colonized mechanically ventilated patientsGram negative pneumonia in heavily colonized mechanically ventilated patientsMedDRA version: 20.0Level: LLTClassification code 10035725Term: Pneumonia NOSSystem Organ Class: 100000004862EUCTR2018-003865-32-ESAlejandro Rodriguez Oviedo - Critical Care Department – Hospital Universitario de Tarragona Joan XXIII20
招募中
2 期
Evaluation of Firooz fissure cream containing lanolin in improving the pain and severity of fissure lesionsFissure of nipple.Fissure and fistula of nippleN64.0IRCT20190210042676N27Firooz Health Group Company20
尚未招募
2 期
Phase II Clinical Trial: Efficacy and Safety of Kaempferia Parviflora in Treatment of Chronic Vertigo PatientsDizzinessKaempferia parviflora,chronic vertigo,Dizziness Handicap Inventory,Vestibular functionTCTR20181122001Agricultural Research Development Agency (Public Organization)72
进行中（未招募）
1 期
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 (N9-GP) in Previously Treated Children withHaemophilia BHaemophilia BMedDRA version: 14.1Level: LLTClassification code 10018939Term: Haemophilia B (Factor IX)System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-000826-31-DEovo Nordisk24